Retrospective Natural History Study of Retinitis Pigmentosa
NCT ID: NCT03975543
Last Updated: 2021-08-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
113 participants
OBSERVATIONAL
2018-10-01
2021-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prospective Natural History Study of Retinitis Pigmentosa
NCT04285398
A Natural History Study to Evaluate Functional and Anatomical Progression in Retinitis Pigmentosa
NCT04558983
Clinical and Genetic Findings in Patients With PRPF31-associated Retinitis Pigmentosa
NCT06368375
Retinitis Pigmentosa Clinical Measures and Repeatability Testing of Potential Outcome Measures
NCT03845218
A Prospective, Observational Study in Adults With Retinitis Pigmentosa (RP)
NCT06517940
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
113 participants will be enrolled in this study at the single center: CHNO-CIC Quinze-Vingt Paris in France.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Patients with any ocular disorder other than RP, likely to impact the retinal function.
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
SparingVision
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHNO XV-XX Paris - CIC 1423
Paris, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PHENOROD1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.